announces

Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:

SEOUL, South Korea and NEW YORK, June 20, 2025 /PRNewswire/ -- Parataxis Holdings LLC ("Parataxis Holdings"), an affiliate of Parataxis Capital…

6 months ago

Flexsys Announces Price Increase for Insoluble Sulfur in India

AKRON, Ohio, June 18, 2025 /PRNewswire/ -- Flexsys has announced that it will increase the price of Insoluble Sulfur products…

6 months ago

Red Cat Holdings Announces Closing of $46.75 Million Registered Direct Offering of Common Stock

June 18, 2025 16:05 ET  | Source: Red Cat Holdings, Inc. SAN JUAN, Puerto Rico, June 18, 2025 (GLOBE NEWSWIRE)…

6 months ago

Vincerx Pharma, Inc. Announces Adjournment of Special Meeting – Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal

SAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the Special…

6 months ago

The Block Announces Strategic Leadership Evolution as Leading Digital Asset News Platform Enters Next Growth Phase

Larry Cermak transitions to President role to focus on research and product innovation; Kaleb Jessee promoted to CEO NEW YORK,…

6 months ago

Hyundai Motor Group Announces Grand Prix Recipient and Exhibitions of the 6th VH AWARD

Hyundai Motor Group premieres five commissioned artworks of the 6th VH AWARD screening at HEK (House of Electronic Arts) during…

6 months ago

Ubyx, The Stablecoin Clearing System Enabling Bank & Fintech Off-Ramps, Announces $10M Seed Led by Galaxy Ventures

Ubyx is founded by 30-Year Payments Veteran to Build Global Stablecoin Acceptance Network NEW YORK, June 17, 2025 /PRNewswire/ --…

6 months ago

ValueLabs Announces Plans to Become the Enterprise OS of the Agentic Era

HYDERABAD, India, June 16, 2025 /PRNewswire/ -- ValueLabs, a global technology services and AI solutions company, today announced its plans…

6 months ago

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…

6 months ago

Vaxart Announces Preliminary Results of Annual Meeting of Stockholders

June 13, 2025 16:52 ET  | Source: Vaxart, Inc. SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart,…

6 months ago